Lotus Pharmaceuticals

(OTC) LTUS

Current Price$0.00

Market Cap$96.00K

Since IPO (2006)-100%

5 Year-91%

1 Year-56%

1 Month-4%

Lotus Pharmaceuticals Financials at a Glance

Market Cap

$96.00K

Revenue (TTM)

$0.00

Net Income (TTM)

-$33.77K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-0.40 (Low)

Dividend

$0.00

Beta (Volatility)

-0.40 (Low)

Price

$0.00

Volume

28,000

Open

$0.00

Price

$0.00

Volume

28,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

May 15, 2026

Dividend

$0.00

Beta (Volatility)

-0.40 (Low)

Price

$0.00

Volume

28,000

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.01

Estimated Earnings Date

May 15, 2026

LTUS News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lotus Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Georgene Rivers

Website

lotuspharmaceuticalsusa.com

Headquarters

Nashville, TN 37207, US

LTUS Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

Return on Assets

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$96.00K

Shares Outstanding

27.82M

Volume

28.00K

Avg. Volume

2.89K

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$29.03K

EBITDA

-$29.03K

Operating Cash Flow

-$19.13K

Capital Expenditure

$0.00

Free Cash Flow

-$19.13K

Cash & ST Invst.

$1.90K

Total Debt

$116.68K

Lotus Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$96.00K

N/A

Market Cap/Employee

$412.02

N/A

Employees

233

N/A

Net Income

-$4.74K

-103.9%

EBITDA

-$4.74K

-103.9%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$419.00

+122.9%

Total Debt

$123.43K

+15.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$123.43K

+15.6%

Return on Assets

0.00%

N/A

Return on Invested Capital

0.00%

N/A

Free Cash Flow

-$3.85K

+41.5%

Operating Cash Flow

-$3.85K

+41.5%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AWWIAlpha Wastewater, Inc.

AWWIAlpha Wastewater, Inc.$0.00+0.00%

CHMJFWaverunner Capital Inc.

CHMJFWaverunner Capital Inc.$0.02+0.00%

MNZOManzo Pharmaceuticals, Inc.

MNZOManzo Pharmaceuticals, Inc.$0.00+0.00%

ALDAAtlantica, Inc.

ALDAAtlantica, Inc.$0.05+0.00%

AWONA1 Group, Inc.

AWONA1 Group, Inc.$0.00+17.65%

CDSGChina Dongsheng International, Inc.

CDSGChina Dongsheng International, Inc.$0.00-24.07%

VNTAVentana Biotech, Inc.

VNTAVentana Biotech, Inc.$0.06+59.46%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$160.95+0.19%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

Questions About LTUS

What is the current price of Lotus Pharmaceuticals?

Lotus Pharmaceuticals is trading at $0.00 per share.

What is the 52-week range for Lotus Pharmaceuticals?

Over the past 52 weeks, Lotus Pharmaceuticals has traded between $0.00 and $0.01.

How much debt does Lotus Pharmaceuticals have?

As of the most recent reporting period, Lotus Pharmaceuticals reported total debt of $306.95K.

How much cash does Lotus Pharmaceuticals have on hand?

Lotus Pharmaceuticals reported $1.45K in cash and cash equivalents in its most recent financial results.

What is Lotus Pharmaceuticals’s dividend yield?

Lotus Pharmaceuticals does not currently have a dividend yield.

Lotus Pharmaceuticals

Lotus Pharmaceuticals Financials at a Glance

LTUS News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Lotus Pharmaceuticals

LTUS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Lotus Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About LTUS

What is the current price of Lotus Pharmaceuticals?

What is the 52-week range for Lotus Pharmaceuticals?

How much debt does Lotus Pharmaceuticals have?

How much cash does Lotus Pharmaceuticals have on hand?

What is Lotus Pharmaceuticals’s dividend yield?

Premium Investing Services